FRED E. COHEN, M.D., D.PHIL.

Corporate Board Profile

Tech Score: 75/100

← Back to All Directors

Software Technology Evidence

3 mention(s) identify FRED E. COHEN, M.D., D.PHIL. as having software/technology expertise.

Company Filing Date Evidence Reason
BIOCRYST PHARMACEUTICALS INC 2015-04-10 His research interests include structure based drug design, prion diseases, computational biology and heteropolymer chemistry. Dr. Cohen received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship. Dr. Cohen has a B.S. in Molecular Biophysics and Biochemistry, a D.Phil. in Molecular Biophysics, and research interests including computational biology, indicating technical skills related to programming.
BIOCRYST PHARMACEUTICALS INC 2016-04-11 His research interests include structure based drug design, prion diseases, computational biology and heteropolymer chemistry. Dr. Cohen received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship, his M.D. from Stanford and his postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF. Dr. Cohen has a D.Phil. in Molecular Biophysics, research interests including computational biology, and extensive scientific and technical expertise indicating ability to write programs.
BIOCRYST PHARMACEUTICALS INC 2018-05-10 His research interests include structure based drug design, prion diseases, computational biology and heteropolymer chemistry. Dr. Cohen received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship. Dr. Cohen has a D.Phil. in Molecular Biophysics, research interests including computational biology, and experience in molecular biophysics, indicating technical skills relevant to programming.

BIOCRYST PHARMACEUTICALS INC

Filing Date Source Excerpt
2015-04-10 His research interests include structure based drug design, prion diseases, computational biology and heteropolymer chemistry. Dr. Cohen received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship.
2016-04-11 His research interests include structure based drug design, prion diseases, computational biology and heteropolymer chemistry. Dr. Cohen received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship, his M.D. from Stanford and his postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF.
2017-04-12 Dr. Cohen received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship, his M.D. from Stanford and his postdoctoral training and postgraduate medical training in Internal Medicine and Endocrinology at UCSF.
2018-05-10 His research interests include structure based drug design, prion diseases, computational biology and heteropolymer chemistry. Dr. Cohen received his B.S. degree in Molecular Biophysics and Biochemistry from Yale University, his D.Phil. in Molecular Biophysics from Oxford on a Rhodes Scholarship.

Data sourced from SEC filings. Last updated: 2025-10-11